Dr. Cella on the Value of Patient-Reported Outcomes

onclivetv has 407 videos Subscribe Here

Description: David Cella, PhD, a clinical research specialist and chair of the Department of Medical Social Science at Northwestern University Feinberg School of Medicine in Chicago explains the value of the patient-reported outcomes discovered as the lead investigator of the patient-reported outcomes phase III AXIS trial comparing axitinib to sorafenib as second-line therapy for metastatic renal cell carcinoma (mRCC).
Shared By : onclivetv
Posted on : 07/06/11
Added : 8 years ago
Category :